A 0 1 0 1 O
confirmed 2 11 2 11 O
tumor 12 17 12 17 B-cancer
site 18 22 18 22 O
is 23 25 23 25 O
one 26 29 26 29 O
in 30 32 30 32 O
which 33 38 33 38 O
is 39 41 39 41 O
biopsy 42 48 42 48 B-treatment
- 48 49 48 49 I-treatment
proven 49 55 49 55 I-treatment
with 56 60 56 60 O
the 61 64 61 64 O
exception 65 74 65 74 O
of 75 77 75 77 O
brainstem 78 87 78 87 B-cancer
glioma 88 94 88 94 I-cancer
which 95 100 95 100 O
will 101 105 101 105 O
be 106 108 106 108 O
eligible 109 117 109 117 O
with 118 122 118 122 O
radiographic 123 135 123 135 B-treatment
diagnosis 136 145 136 145 O

A 0 1 146 147 O
pregnancy 2 11 148 157 B-pregnancy
test 12 16 158 162 O
will 17 21 163 167 O
be 22 24 168 170 O
performed 25 34 171 180 O
on 35 37 181 183 O
each 38 42 184 188 O
premenopausal 43 56 189 202 O
female 57 63 203 209 B-gender
of 64 66 210 212 O
childbearing 67 79 213 225 O
potential 80 89 226 235 O
immediately 90 101 236 247 O
prior 102 107 248 253 O
to 108 110 254 256 O
entry 111 116 257 262 O
into 117 121 263 267 O
the 122 125 268 271 O
research 126 134 272 280 O
study 135 140 281 286 O

Because 0 7 287 294 O
of 8 10 295 297 O
known 11 16 298 303 O
concerns 17 25 304 312 O
with 26 30 313 317 O
Avastin 31 38 318 325 B-treatment
and 39 42 326 329 O
wound 43 48 330 335 O
healing 49 56 336 343 O

Craniotomy 0 10 344 354 B-treatment
or 11 13 355 357 O
major 14 19 358 363 B-treatment
procedure 20 29 364 373 I-treatment
after 30 35 374 379 O
SIACI 36 41 380 385 B-treatment
Avastin 42 49 386 393 I-treatment
therapy 50 57 394 401 I-treatment
should 58 64 402 408 O
wait 65 69 409 413 O
4 70 71 414 415 O
weeks 72 77 416 421 O

Females 0 7 422 429 B-gender
of 8 10 430 432 O
childbearing 11 23 433 445 O
potential 24 33 446 455 O
and 34 37 456 459 O
fertile 38 45 460 467 O
men 46 49 468 471 B-gender
will 50 54 472 476 O
be 55 57 477 479 O
informed 58 66 480 488 O
as 67 69 489 491 O
to 70 72 492 494 O
the 73 76 495 498 O
potential 77 86 499 508 O
risk 87 91 509 513 O
of 92 94 514 516 O
procreation 95 106 517 528 O
while 107 112 529 534 O
participating 113 126 535 548 O
in 127 129 549 551 O
this 130 134 552 556 O
research 135 143 557 565 B-treatment
trial 144 149 566 571 I-treatment
and 150 153 572 575 O
will 154 158 576 580 O
be 159 161 581 583 O
advised 162 169 584 591 O
that 170 174 592 596 O
they 175 179 597 601 O
must 180 184 602 606 O
use 185 188 607 610 B-contraception_consent
effective 189 198 611 620 I-contraception_consent
contraception 199 212 621 634 I-contraception_consent
during 213 219 635 641 O
and 220 223 642 645 O
for 224 227 646 649 O
a 228 229 650 651 O
period 230 236 652 658 O
of 237 239 659 661 O
three 240 245 662 667 B-upper_bound
months 246 252 668 674 I-upper_bound
after 253 258 675 680 O
the 259 262 681 684 O
treatment 263 272 685 694 O
period 273 279 695 701 O

Females 0 7 702 709 B-gender
who 8 11 710 713 O
are 12 15 714 717 B-pregnancy
pregnant 16 24 718 726 I-pregnancy
or 25 27 727 729 O
lactating 28 37 730 739 O

Male 0 4 740 744 B-gender
or 5 7 745 747 I-gender
female 8 14 748 754 I-gender
patients 15 23 755 763 I-gender
, 23 24 763 764 O
under 25 30 765 770 O
22 31 33 771 773 B-upper_bound
years 34 39 774 779 I-upper_bound
of 40 42 780 782 O
age 43 46 783 786 B-age

Minor 0 5 787 792 B-treatment
surgeries 6 15 793 802 I-treatment
may 16 19 803 806 O
be 20 22 807 809 O
performed 23 32 810 819 O
after 33 38 820 825 O
two 39 42 826 829 B-upper_bound
weeks 43 48 830 835 I-upper_bound

No 0 2 836 838 O
chemotherapy 3 15 839 851 B-treatment
for 16 19 852 855 O
three 20 25 856 861 B-upper_bound
weeks 26 31 862 867 I-upper_bound
prior 32 37 868 873 I-upper_bound
to 38 40 874 876 O
treatment 41 50 877 886 B-treatment
under 51 56 887 892 O
this 57 61 893 897 O
research 62 70 898 906 O
protocol 71 79 907 915 O
and 80 83 916 919 O
no 84 86 920 922 O
external 87 95 923 931 O
beam 96 100 932 936 O
radiation 101 110 937 946 O
for 111 114 947 950 O
eight 115 120 951 956 B-upper_bound
weeks 121 126 957 962 I-upper_bound
prior 127 132 963 968 I-upper_bound
to 133 135 969 971 O
treatment 136 145 972 981 O
under 146 151 982 987 O
this 152 156 988 992 O
research 157 165 993 1001 O
protocol 166 174 1002 1010 O

Patients 0 8 1011 1019 O
must 9 13 1020 1024 O
have 14 18 1025 1029 O
a 19 20 1030 1031 O
Karnofsky 21 30 1032 1041 B-clinical_variable
or 31 33 1042 1044 O
Lansky 34 40 1045 1051 B-clinical_variable
performance 41 52 1052 1063 I-clinical_variable
status 53 59 1064 1070 I-clinical_variable
70 60 62 1071 1073 O
% 62 63 1073 1074 O
. 63 64 1074 1075 O
Karnofsky 65 74 1076 1085 O
is 75 77 1086 1088 O
used 78 82 1089 1093 O
for 83 86 1094 1097 O
patients 87 95 1098 1106 O
older 96 101 1107 1112 O
than 102 106 1113 1117 O
or 107 109 1118 1120 O
equal 110 115 1121 1126 O
to 116 118 1127 1129 O
the 119 122 1130 1133 O
age 123 126 1134 1137 B-age
of 127 129 1138 1140 O
16 130 132 1141 1143 O
years 133 138 1144 1149 O
and 139 142 1150 1153 O
Lansky 143 149 1154 1160 O
for 150 153 1161 1164 O
those 154 159 1165 1170 O
under 160 165 1171 1176 O
16 166 168 1177 1179 O
years 169 174 1180 1185 O
old 175 178 1186 1189 O
and 179 182 1190 1193 O
an 183 185 1194 1196 O
expected 186 194 1197 1205 B-clinical_variable
survival 195 203 1206 1214 I-clinical_variable
three 204 209 1215 1220 B-lower_bound
months 210 216 1221 1227 I-lower_bound

Patients 0 8 1228 1236 O
must 9 13 1237 1241 O
have 14 18 1242 1246 O
adequate 19 27 1247 1255 O
hematologic 28 39 1256 1267 O
reserve 40 47 1268 1275 O
with 48 52 1276 1280 O
absolute 53 61 1281 1289 B-clinical_variable
neutrophils 62 73 1290 1301 I-clinical_variable
greater 74 81 1302 1309 O
than 82 86 1310 1314 O
or 87 89 1315 1317 O
equal 90 95 1318 1323 O
to 96 98 1324 1326 O
1000 99 103 1327 1331 B-lower_bound
/ 103 104 1331 1332 I-lower_bound
mm3 104 107 1332 1335 I-lower_bound
and 108 111 1336 1339 O
platelets 112 121 1340 1349 B-clinical_variable
greater 122 129 1350 1357 O
than 130 134 1358 1362 O
or 135 137 1363 1365 O
equal 138 143 1366 1371 O
100,000 144 151 1372 1379 B-lower_bound
/ 151 152 1379 1380 I-lower_bound
mm3 152 155 1380 1383 I-lower_bound

Patients 0 8 1384 1392 O
must 9 13 1393 1397 O
have 14 18 1398 1402 O
at 19 21 1403 1405 O
least 22 27 1406 1411 O
one 28 31 1412 1415 B-lower_bound
confirmed 32 41 1416 1425 O
and 42 45 1426 1429 O
evaluable 46 55 1430 1439 O
tumor 56 61 1440 1445 B-cancer
site 62 66 1446 1450 O

Patients 0 8 1451 1459 O
of 9 11 1460 1462 O
reproductive 12 24 1463 1475 O
age 25 28 1476 1479 B-age
must 29 33 1480 1484 O
agree 34 39 1485 1490 B-contraception_consent
to 40 42 1491 1493 I-contraception_consent
use 43 46 1494 1497 I-contraception_consent
a 47 48 1498 1499 I-contraception_consent
medically 49 58 1500 1509 I-contraception_consent
effective 59 68 1510 1519 I-contraception_consent
method 69 75 1520 1526 I-contraception_consent
of 76 78 1527 1529 I-contraception_consent
contraception 79 92 1530 1543 I-contraception_consent
during 93 99 1544 1550 O
and 100 103 1551 1554 O
for 104 107 1555 1558 O
a 108 109 1559 1560 O
period 110 116 1561 1567 O
of 117 119 1568 1570 O
three 120 125 1571 1576 B-upper_bound
months 126 132 1577 1583 I-upper_bound
after 133 138 1584 1589 I-upper_bound
the 139 142 1590 1593 O
treatment 143 152 1594 1603 B-treatment
period 153 159 1604 1610 O

Patients 0 8 1611 1619 O
with 9 13 1620 1624 O
CNS 14 17 1625 1628 B-cancer
tumors 18 24 1629 1635 I-cancer
who 25 28 1636 1639 O
are 29 32 1640 1643 O
receiving 33 42 1644 1653 O
dexamethasone 43 56 1654 1667 B-treatment
must 57 61 1668 1672 O
be 62 64 1673 1675 O
on 65 67 1676 1678 O
a 68 69 1679 1680 O
stable 70 76 1681 1687 O
or 77 79 1688 1690 O
decreasing 80 90 1691 1701 O
dose 91 95 1702 1706 O
for 96 99 1707 1710 O
at 100 102 1711 1713 O
least 103 108 1714 1719 O
1 109 110 1720 1721 B-lower_bound
week 111 115 1722 1726 I-lower_bound
prior 116 121 1727 1732 I-lower_bound
to 122 124 1733 1735 O
study 125 130 1736 1741 O
entry 131 136 1742 1747 O

Patients 0 8 1748 1756 O
with 9 13 1757 1761 O
significant 14 25 1762 1773 O
concurrent 26 36 1774 1784 O
medical 37 44 1785 1792 O
or 45 47 1793 1795 O
psychiatric 48 59 1796 1807 B-treatment
conditions 60 70 1808 1818 I-treatment
that 71 75 1819 1823 O
would 76 81 1824 1829 O
place 82 87 1830 1835 O
them 88 92 1836 1840 O
at 93 95 1841 1843 O
increased 96 105 1844 1853 O
risk 106 110 1854 1858 O
or 111 113 1859 1861 O
affect 114 120 1862 1868 O
their 121 126 1869 1874 O
ability 127 134 1875 1882 O
to 135 137 1883 1885 O
receive 138 145 1886 1893 O
or 146 148 1894 1896 O
comply 149 155 1897 1903 O
with 156 160 1904 1908 O
treatment 161 170 1909 1918 B-treatment
or 171 173 1919 1921 O
post 174 178 1922 1926 B-treatment
- 178 179 1926 1927 I-treatment
treatment 179 188 1927 1936 I-treatment
clinical 189 197 1937 1945 O
monitoring 198 208 1946 1956 O

Pre 0 3 1957 1960 O
- 3 4 1960 1961 O
enrollment 4 14 1961 1971 O
chemistry 15 24 1972 1981 O
parameters 25 35 1982 1992 O
must 36 40 1993 1997 O
show 41 45 1998 2002 O
: 45 46 2002 2003 O
bilirubin 47 56 2004 2013 B-clinical_variable
less 57 61 2014 2018 O
than 62 66 2019 2023 O
1.5X 67 71 2024 2028 B-upper_bound
the 72 75 2029 2032 I-upper_bound
institutional 76 89 2033 2046 I-upper_bound
upper 90 95 2047 2052 I-upper_bound
limit 96 101 2053 2058 I-upper_bound
of 102 104 2059 2061 I-upper_bound
normal 105 111 2062 2068 I-upper_bound
( 112 113 2069 2070 I-upper_bound
IUNL 113 117 2070 2074 I-upper_bound
) 117 118 2074 2075 I-upper_bound
; 118 119 2075 2076 O
AST 120 123 2077 2080 B-clinical_variable
or 124 126 2081 2083 O
ALT 127 130 2084 2087 B-clinical_variable
less 131 135 2088 2092 O
than 136 140 2093 2097 O
2.5X 141 145 2098 2102 B-upper_bound
IUNL 146 150 2103 2107 I-upper_bound
and 151 154 2108 2111 O
creatinine 155 165 2112 2122 B-clinical_variable
less 166 170 2123 2127 O
than 171 175 2128 2132 O
1.5X 176 180 2133 2137 B-upper_bound
IUNL 181 185 2138 2142 I-upper_bound

Pre 0 3 2143 2146 B-clinical_variable
- 3 4 2146 2147 I-clinical_variable
enrollment 4 14 2147 2157 I-clinical_variable
coagulation 15 26 2158 2169 I-clinical_variable
parameters 27 37 2170 2180 I-clinical_variable
( 38 39 2181 2182 I-clinical_variable
PT 39 41 2182 2184 I-clinical_variable
and 42 45 2185 2188 I-clinical_variable
PTT 46 49 2189 2192 I-clinical_variable
) 49 50 2192 2193 I-clinical_variable
must 51 55 2194 2198 O
be 56 58 2199 2201 O
less 59 63 2202 2206 O
than 64 68 2207 2211 O
1.5X 69 73 2212 2216 B-upper_bound
the 74 77 2217 2220 I-upper_bound
IUNL 78 82 2221 2225 I-upper_bound

Previous 0 8 2226 2234 O
treatment 9 18 2235 2244 B-treatment
with 19 23 2245 2249 O
Avastin 24 31 2250 2257 B-treatment
and 32 35 2258 2261 O
Cetuximab 36 45 2262 2271 B-treatment

Radiographic 0 12 2272 2284 B-treatment
procedures 13 23 2285 2295 I-treatment
( 24 25 2296 2297 O
e.g. 25 29 2297 2301 O
, 29 30 2301 2302 O
Gd 31 33 2303 2305 B-treatment
- 33 34 2305 2306 I-treatment
enhanced 34 42 2306 2314 I-treatment
MRI 43 46 2315 2318 I-treatment
or 47 49 2319 2321 O
CT 50 52 2322 2324 B-treatment
scans 53 58 2325 2330 I-treatment
) 58 59 2330 2331 O
documenting 60 71 2332 2343 O
existing 72 80 2344 2352 O
lesions 81 88 2353 2360 O
must 89 93 2361 2365 O
have 94 98 2366 2370 O
been 99 103 2371 2375 O
performed 104 113 2376 2385 O
within 114 120 2386 2392 O
three 121 126 2393 2398 B-upper_bound
weeks 127 132 2399 2404 I-upper_bound
of 133 135 2405 2407 O
treatment 136 145 2408 2417 B-treatment
on 146 148 2418 2420 O
this 149 153 2421 2425 O
research 154 162 2426 2434 O
study 163 168 2435 2440 O

Steroids 0 8 2441 2449 B-treatment
: 8 9 2449 2450 O
Systemic 10 18 2451 2459 B-treatment
corticosteroid 19 33 2460 2474 I-treatment
therapy 34 41 2475 2482 I-treatment
is 42 44 2483 2485 O
permissible 45 56 2486 2497 O
in 57 59 2498 2500 O
patients 60 68 2501 2509 O
with 69 73 2510 2514 O
CNS 74 77 2515 2518 B-cancer
tumors 78 84 2519 2525 I-cancer
for 85 88 2526 2529 O
treatment 89 98 2530 2539 B-treatment
of 99 101 2540 2542 O
increased 102 111 2543 2552 B-chronic_disease
intracranial 112 124 2553 2565 I-chronic_disease
pressure 125 133 2566 2574 I-chronic_disease
or 134 136 2575 2577 O
symptomatic 137 148 2578 2589 O
tumor 149 154 2590 2595 B-cancer
edema 155 160 2596 2601 I-cancer

a 0 1 2602 2603 O
documented 2 12 2604 2614 O
histologic 13 23 2615 2625 O
diagnosis 24 33 2626 2635 O
of 34 36 2636 2638 O
relapsed 37 45 2639 2647 O
or 46 48 2648 2650 O
refractory 49 59 2651 2661 O
glioblastoma 60 72 2662 2674 B-cancer
multiforme 73 83 2675 2685 I-cancer
( 84 85 2686 2687 I-cancer
GBM 85 88 2687 2690 I-cancer
) 88 89 2690 2691 I-cancer

anaplastic 0 10 2692 2702 B-cancer
astrocytoma 11 22 2703 2714 I-cancer
( 23 24 2715 2716 I-cancer
AA 24 26 2716 2718 I-cancer
) 26 27 2718 2719 I-cancer

anaplastic 0 10 2720 2730 B-cancer
mixed 11 16 2731 2736 I-cancer
oligoastrocytoma 17 33 2737 2753 I-cancer
( 34 35 2754 2755 I-cancer
AOA 35 38 2755 2758 I-cancer
) 38 39 2758 2759 I-cancer

craniotomy 0 10 2760 2770 B-treatment
patients 11 19 2771 2779 O
are 20 23 2780 2783 O
eligible 24 32 2784 2792 O
for 33 36 2793 2796 O
the 37 40 2797 2800 O
treatment 41 50 2801 2810 B-treatment
if 51 53 2811 2813 O
they 54 58 2814 2818 O
have 59 63 2819 2823 O
had 64 67 2824 2827 O
a 68 69 2828 2829 O
craniotomy 70 80 2830 2840 O
greater 81 88 2841 2848 O
than 89 93 2849 2853 O
two 94 97 2854 2857 B-lower_bound
weeks 98 103 2858 2863 I-lower_bound
prior 104 109 2864 2869 I-lower_bound
to 110 112 2870 2872 O
IA 113 115 2873 2875 B-treatment
therapy 116 123 2876 2883 I-treatment

fibrillary 0 10 2884 2894 B-cancer
astrocytomas 11 23 2895 2907 I-cancer
( 24 25 2908 2909 I-cancer
FA 25 27 2909 2911 I-cancer
) 27 28 2911 2912 I-cancer

oligodendroglioma 0 17 2913 2930 B-cancer

pilomyxoid 0 10 2931 2941 B-cancer
astrocytoma 11 22 2942 2953 I-cancer
( 23 24 2954 2955 I-cancer
PXA 24 27 2955 2958 I-cancer
) 27 28 2958 2959 I-cancer

radiologically 0 14 2960 2974 O
diagnosed 15 24 2975 2984 O
brainstem 25 34 2985 2994 B-cancer
glioma 35 41 2995 3001 I-cancer

